Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bossow

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biological Chemistry|December 29, 1998
Characterization of the chicken and rat DCoH gene domains using an improved ligation-mediated PCR methodS Bossow, S Riepl, T Igo-Kemenes
Journal of Virological Methods|February 1, 2022
Robust envelope exchange platform for oncolytic measles virusS Neault, S Bossow, C Achard, et al.
Gene Therapy|May 31, 2013
An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosisJ Lampe, S Bossow, T Weiland, et al.
Cancer Gene Therapy|November 15, 2011
Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virusK Zaoui, S Bossow, C Grossardt, et al.
Cancer Gene Therapy|June 25, 2011
Armed and targeted measles virus for chemovirotherapy of pancreatic cancerS Bossow, C Grossardt, A Temme, et al.
Gynecologic Oncology|May 17, 2013
Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferaseA D Hartkopf, S Bossow, J Lampe, et al.
Cancer Gene Therapy|August 23, 2014
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virusM A Baertsch, M F Leber, S Bossow, et al.
Gene Therapy|January 16, 2004
Reduced toxicity of F-deficient Sendai virus vector in the mouse fetusS N Waddington, S M K Buckley, C Bernloehr, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biological Chemistry|December 29, 1998
Characterization of the chicken and rat DCoH gene domains using an improved ligation-mediated PCR methodS Bossow, S Riepl, T Igo-Kemenes
Journal of Virological Methods|February 1, 2022
Robust envelope exchange platform for oncolytic measles virusS Neault, S Bossow, C Achard, et al.
Gene Therapy|May 31, 2013
An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosisJ Lampe, S Bossow, T Weiland, et al.
Cancer Gene Therapy|November 15, 2011
Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virusK Zaoui, S Bossow, C Grossardt, et al.
Cancer Gene Therapy|June 25, 2011
Armed and targeted measles virus for chemovirotherapy of pancreatic cancerS Bossow, C Grossardt, A Temme, et al.
Gynecologic Oncology|May 17, 2013
Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferaseA D Hartkopf, S Bossow, J Lampe, et al.
Cancer Gene Therapy|August 23, 2014
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virusM A Baertsch, M F Leber, S Bossow, et al.
Gene Therapy|January 16, 2004
Reduced toxicity of F-deficient Sendai virus vector in the mouse fetusS N Waddington, S M K Buckley, C Bernloehr, et al.
Pageof 1